Developer docs
API playgroundTry for free, no card

Search company profiles

ArisGlobal

Full company profile

uuid0005bag

Namestring
ArisGlobal
Legal namestring
ArisGlobal LLC
Websiteurl
arisglobal.com
Company typeenum
Private
Founded yearint
1987
Descriptiontext

ArisGlobal is a private, PE-backed (Nordic Capital) SaaS company that builds AI-native software for the life sciences industry, headquartered in Waltham, MA with operations in eight countries and ~1,500 professionals. Founded in 1987 with the first commercially available drug safety system, the company now offers the LifeSphere platform covering four end-to-end R&D compliance domains: pharmacovigilance (Safety), regulatory affairs, quality management, and medical affairs. Its flagship LifeSphere Safety product MultiVigilance is positioned as an industry-first end-to-end touchless case processing system, complemented by Advanced Intake, Literature Intelligence, ReporterX, Advanced Signals, Business Intelligence, Document Distribution, and Advanced Compliance Docs modules. The LifeSphere Regulatory suite spans RIM, Product Compliance, Documents, Submissions, Labeling, Analytics, Health Authority Interactions, and Regulatory Intelligence. LifeSphere Quality and LifeSphere Medical Affairs extend coverage to adjacent R&D workflows.

The company's technical differentiator is the NavaX cognitive computing engine, launched in late 2023, which delivers GenAI and Agentic AI capabilities across the entire platform. NavaX powers the NavaX Agents suite (MedDRA Coding Agent, Signals Agents, Distribution Agents, Intelligence Agents), NavaX Translation (via partnership with TransPerfect Life Sciences), and the newly launched XDI (Data Intelligence Cortex), a federated data intelligence platform unifying clinical, regulatory, PV, and quality data. The platform processes over 700,000 safety cases annually as of 2025, scaling to a projected 2.5 million by mid-2026, providing a proprietary data flywheel. Notable integrations include PubMed/Medline/Embase (literature), Spotfire (analytics), and AWS/Azure/Google/Snowflake infrastructure.

ArisGlobal operates a subscription SaaS revenue model with enterprise, quote-based pricing negotiated annually per customer. Go-to-market is direct enterprise field sales complemented by a partner ecosystem of system integrators (Accenture, Cognizant, Pinaxis, SYNRG, Navitas) and technology partners (AWS, Microsoft, Google, Snowflake). The company serves 220+ enterprise customers across global pharmaceutical companies (including 3 of the world's top 10 and named customers Roche, AstraZeneca, Boehringer Ingelheim, Astellas), CROs (EPS Corporation, Nippon Shinyaku), and government health authorities (FDA, Health Canada, NMPA). Distribution is global with offices in the United States, United Kingdom, Ireland, Germany, Croatia, Japan, China, and India; annual Breakthrough events serve as flagship GTM touchpoints for major product launches.

Short descriptiontext

ArisGlobal is a private, PE-backed SaaS provider of AI-native life sciences R&D compliance software covering pharmacovigilance, regulatory affairs, quality, and medical affairs, serving 220+ global pharma, CRO, and health authority customers via its LifeSphere platform and NavaX cognitive engine.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersWaltham, United States
HQ citystring
Waltham
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices9 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmacovigilance software, regulatory information management, drug safety solutions, life sciences compliance software, medical affairs platform
Industry4 codes
PRIMARYHLAGAJAK
Pharmacovigilance & Drug Safety Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAL
Regulatory Information Management (RIM) & Submission Publishing Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAC
Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
NAICS code1 code
  • Software Publishers5132
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Life Sciences R&D Software
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1SaaS Platform Subscriptions (LifeSphere)
TypeSubscription Recurring
Description

ArisGlobal operates on a subscription/SaaS model for its LifeSphere platform, charging enterprise customers recurring fees for access to pharmacovigilance, regulatory, quality, and medical affairs software. The platform is described as a next-generation SaaS safety and regulatory platform, with cloud-based deployment and multi-tenant architecture enabling scalable compliance. Pricing is quote-based and negotiated at the enterprise level.

arisglobal.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Enterprise SaaS subscription — pricing not publicly disclosed
ModelSubscriptionBilling cadenceAnnual
Notes

No public pricing available. Enterprise customers engage via 'Book a Demo' and ROI calculators. Pricing negotiated per customer based on modules selected, user count, and deployment scope.

arisglobal.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 12 records shown
1LifeSphere
Description

AI-powered SaaS platform for life sciences R&D covering Safety, Regulatory, Quality, and Medical Affairs

arisglobal.com
+11 more records
Core offering1 text field

ArisGlobal provides LifeSphere, an AI-first multi-tenant SaaS platform for life sciences R&D that unifies pharmacovigilance (drug safety), regulatory affairs, quality management, and medical affairs on a single cloud platform. The platform is powered by NavaX, a next-generation cognitive computing engine delivering GenAI and Agentic AI capabilities, and includes the MultiVigilance end-to-end automated touchless case processing system, AI-driven safety intake, signal detection, regulatory submissions, IDMP compliance (SPORIFY), and federated data intelligence via XDI.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 15 values shown
  • Up to 65% increased efficiency via safety case intake automation
+14 more records
Product overview1 text field

ArisGlobal offers LifeSphere, a unified platform-plus-modules architecture for life sciences R&D with integrated solutions across Safety, Regulatory, Quality, and Medical Affairs. The core LifeSphere Safety platform provides end-to-end pharmacovigilance via MultiVigilance (touchless case processing), Advanced Intake (GenAI-powered data extraction), Literature Intelligence, ReporterX, Advanced Signals, Business Intelligence, Document Distribution, and Advanced Compliance Docs. LifeSphere Regulatory spans RIM, Product Compliance, Documents, Submissions, Labeling, Analytics, Health Authority Interactions, and Regulatory Intelligence. LifeSphere Medical Affairs and LifeSphere Quality extend the platform. NavaX serves as the AI cognitive engine powering GenAI and Agentic AI capabilities across all modules, while XDI provides federated data intelligence. SPORIFY addresses IDMP compliance. All modules interoperate within the LifeSphere Unify R&D compliance platform.

Product and service17 records
1LifeSphere Safety
CategoryPharmacovigilance Platform
Description

Unified, next-generation SaaS safety platform providing end-to-end pharmacovigilance operations with touchless case processing, scalable compliance, and standardized global workflows. Powered by NavaX AI capabilities. For global pharma, biotech, and CRO safety teams.

2MultiVigilance
CategoryPharmacovigilance Operations
Description

End-to-end automated touchless case processing system for pharmacovigilance operations. Built to help safety teams achieve scalable, efficient, and harmonized case management while improving patient safety and compliance. Extended to medical device safety compliance.

3Advanced Intake
CategorySafety Case Intake Automation
Description

Safety case intake automation solution leveraging cutting-edge GenAI and LLMs to streamline collection of safety data from diverse sources. Achieves up to 65% increased intake efficiency with over 90% data extraction accuracy.

4Literature Intelligence
CategoryLiterature Monitoring
Description

System-agnostic, GenAI-powered solution for literature intake and assessment. Automates workflows for literature screening from days to minutes, replacing manual processes with end-to-end automation for increased efficiency and data accuracy.

5ReporterX
CategoryAdverse Event Reporting
Description

Intelligent front-end patient data collection and reporting application powered by NavaX. Secure mobile and web applications enabling stakeholders to report adverse events, medical information, and product quality complaints with AI-assisted capabilities across 32+ languages.

6Advanced Signals
CategorySignal Detection
Description

Next-generation signaling innovation setting a new standard in safety signaling via end-to-end signal and risk management. Includes AI-powered Signals Intelligence and Signals Agents for agentic AI-powered decision-making in signal management.

7Business Intelligence
CategorySafety Analytics
Description

Unified hub for safety reporting, analytics, and visualization. Provides over 50 out-of-the-box industry-standard reports for regulatory, compliance, and operational use, with intelligent analytics powered by Spotfire.

8Document Distribution
CategorySafety Document Distribution
Description

Single automated platform for oversight and distribution of safety content. Enables real-time distribution of safety reports to key stakeholder groups with audit readiness and customizable dashboards.

9Advanced Compliance Docs
CategoryMedical Writing / Safety Documentation
Description

Unified platform for managing safety documents and data powered by NavaX. Centralized solution for creating, storing, and managing medical writing, PSMF, PVAs and other critical safety documentation with up to 70% faster medical authoring.

10LifeSphere Regulatory
CategoryRegulatory Information Management
Description

Comprehensive regulatory affairs platform transforming operations with GenAI and Agentic AI capabilities powered by NavaX. Seamlessly brings together data, content, and processes across end-to-end regulatory lifecycle.

11LifeSphere Medical Affairs
CategoryMedical Affairs
Description

Medical affairs platform enabling seamless information flow and automation across Medical Affairs, Safety, and Product Complaints. Natively integrated with Safety and Quality systems via LifeSphere Unify.

12LifeSphere Quality
CategoryQuality Management
Description

Complete solution for quality management and documentation needs of life sciences companies across R&D, Clinical, Regulatory, Pharmacovigilance, and Manufacturing with industry-specific requirements.

13NavaX
CategoryAI Cognitive Engine
Description

Next-gen cognitive computing engine accelerating application of artificial intelligence across LifeSphere platforms. Powers GenAI and Agentic AI capabilities including automation, translation, signal detection, and intelligent agents for life sciences R&D.

14NavaX Agents
CategoryAgentic AI Suite
Description

Suite of AI-powered autonomous agents operating within LifeSphere Unify platform. Includes MedDRA Coding Agent (Frost & Sullivan 2025 New Product Innovation Award winner, up to 80% efficiency gains), Signals Agents, Distribution Agents, and Intelligence Agents for regulatory and safety operations.

15NavaX Translation
CategoryAI-Powered Translation
Description

Translation solution developed through partnership with TransPerfect Life Sciences, embedding certified pharma-grade translation directly into LifeSphere Safety workflows. Reduces translation time from approximately 5 hours to under 1 minute per case, with over 95% data accuracy.

16XDI (Data Intelligence Cortex)
CategoryData Intelligence Platform
Description

Federated data intelligence solution transforming regulated life sciences data into explainable, decision-grade intelligence across pharmacovigilance, regulatory, medical affairs, quality, and benefit-risk functions without requiring data consolidation.

17SPORIFY
CategoryRegulatory Data Standards (IDMP/SPOR)
Description

AI-powered solution for SPOR and ISO IDMP compliance, helping track global regulatory changes and accelerate compliance with pharmaceutical data standards.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership12 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-26
Description

Strategic partnership to embed certified, pharma-grade translation directly into LifeSphere Safety workflows via NavaX Translation. The solution integrates AI-powered language detection and expert human linguists to reduce case translation time from approximately 5 hours to under 1 minute. NavaX Translation leverages TransPerfect's certified translation capabilities to enable compliant multilingual pharmacovigilance operations. The platform currently processes over 1 million safety cases with projections to scale to 2.5 million cases by mid-2026.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-02-19
Description

Strategic partnership to empower life sciences regulatory transformation. Celegence specializes in regulatory compliance and submission solutions, and the partnership aims to enhance ArisGlobal's regulatory offerings and enable faster compliance for shared customers.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-09-06
Description

Expanded strategic partnership to enable best-in-class capabilities across the complete drug development technology platform. The partnership integrates ArisGlobal's safety and regulatory solutions with Sitero's clinical trial technology suite for end-to-end drug development coverage.

Strategic tierCoreTypeImplementation/ SI/ Consulting Partner
Description

System integrator partner within the ArisGlobal Partner Network. Accenture provides consulting and implementation services to help deploy and customize ArisGlobal's LifeSphere platform for enterprise customers across the life sciences sector.

Strategic tierMajorTypeImplementation/ SI/ Consulting Partner
Description

System integrator and business process partner within the ArisGlobal Partner Network. Cognizant provides implementation and consulting services for ArisGlobal platform deployments.

Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

System integrator partner within the ArisGlobal Partner Network providing implementation services for ArisGlobal solutions.

Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

System integrator and business process partner within the ArisGlobal Partner Network.

Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

System integrator partner within the ArisGlobal Partner Network (listed alongside Sitero branding).

Strategic tierCoreTypeTechnology or Integration
Description

Technology partner providing cloud infrastructure for ArisGlobal's SaaS platform. AWS enables the scalable, secure cloud deployment of LifeSphere across global customers.

Strategic tierCoreTypeTechnology or Integration
Description

Technology partner providing cloud infrastructure (Azure) and potentially AI/ML capabilities supporting ArisGlobal's platform.

Strategic tierMajorTypeTechnology or Integration
Description

Technology partner within the ArisGlobal Partner Network, providing cloud infrastructure and potentially AI/ML capabilities.

Strategic tierMajorTypeTechnology or Integration
Description

Technology partner providing data cloud infrastructure enabling ArisGlobal's cross-domain data integration and analytics capabilities.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Veeva's Vault Safety, Vault RIM, Vault Quality, and Vault Submissions directly compete with ArisGlobal's LifeSphere platform across pharmacovigilance, regulatory information management, and quality. Veeva is the most entrenched life sciences SaaS platform with deeper CRM and commercial footprint. ArisGlobal's COO previously led Veeva's Vault Safety practice.

TypeDirect peer
Description

Instem provides software and services for safety assessment, regulatory submissions (Submit suite), and pre-clinical informatics. Directly comparable to ArisGlobal's safety/regulatory modules, particularly for CRO and mid-size pharma segments.

TypeEmerging player
Description

Clario (formerly Bioclinica, where ArisGlobal CEO Aman Wasan previously led Safety and Regulatory Services) provides clinical and safety technology solutions for clinical trials. Partial overlap with ArisGlobal's safety intake and clinical trial informatics via Sitero partnership.

TypeBroad incumbent
Description

IQVIA combines technology (e.g., EDC, RTSM, safety) with CRO and real-world evidence services. Its technology arm competes for life sciences compliance workflows, while its broader services portfolio makes it a one-stop alternative to ArisGlobal's pure-software focus.

TypeBroad incumbent
Description

Parexel is a major CRO with proprietary technology platforms (e.g., PeriNurse, eProm) supporting pharmacovigilance and clinical operations. Competes with ArisGlobal's CRO-targeted MultiVigilance offering through bundled services rather than standalone SaaS.

TypeBroad incumbent
Description

Medidata (a Dassault Systèmes brand) offers the Rave Clinical Cloud (EDC/CTMS/eCOA), BIOVIA for scientific informatics, and broader 3DEXPERIENCE platform for life sciences. Strong overlap with ArisGlobal's clinical trial informatics and scientific data management ambitions, especially relevant given the Sitero partnership.

TypeDirect peer
Description

Honeywell's TrackWise enterprise QMS platform competes directly with ArisGlobal's LifeSphere Quality and Quality Documents modules in regulated life sciences. Broader Honeywell portfolio includes process automation for manufacturing quality.

TypeEmerging player
Description

MaxisIT provides AI-enabled clinical trial and safety technology (EDC, RTSM, safety) targeting mid-size pharma and CROs. Comparable scope to ArisGlobal's clinical informatics modules and pharmacovigilance offerings for similar customer profiles.

9Oracle Health Sciences
TypeBroad incumbent
Description

Oracle's Clinical One platform, Argus Safety (pharmacovigilance), and InForm compete across safety and clinical trials. As a large incumbent ERP/cloud vendor, Oracle offers life sciences capabilities as part of a broader technology portfolio rather than specializing in PV/RIM the way ArisGlobal does.

TypeDirect peer
Description

Ennov provides a unified SaaS platform covering Pharmacovigilance, Regulatory (RIM), and Quality Management for life sciences, closely mirroring ArisGlobal's LifeSphere Safety/Regulatory/Quality portfolio. Mid-size player specializing in the same regulatory and compliance workflows for mid-market pharma.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights8 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration5 records

Each record includes

Title, Type, Description, Source

AI capability12 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature10 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ArisGlobal

Life Sciences R&D Softwarearisglobal.com

ArisGlobal is a private, PE-backed SaaS provider of AI-native life sciences R&D compliance software covering pharmacovigilance, regulatory affairs, quality, and medical affairs, serving 220+ global pharma, CRO, and health authority customers via its LifeSphere platform and NavaX cognitive engine.

What ArisGlobal does

ArisGlobal is a private, PE-backed (Nordic Capital) SaaS company that builds AI-native software for the life sciences industry, headquartered in Waltham, MA with operations in eight countries and ~1,500 professionals. Founded in 1987 with the first commercially available drug safety system, the company now offers the LifeSphere platform covering four end-to-end R&D compliance domains: pharmacovigilance (Safety), regulatory affairs, quality management, and medical affairs. Its flagship LifeSphere Safety product MultiVigilance is positioned as an industry-first end-to-end touchless case processing system, complemented by Advanced Intake, Literature Intelligence, ReporterX, Advanced Signals, Business Intelligence, Document Distribution, and Advanced Compliance Docs modules. The LifeSphere Regulatory suite spans RIM, Product Compliance, Documents, Submissions, Labeling, Analytics, Health Authority Interactions, and Regulatory Intelligence. LifeSphere Quality and LifeSphere Medical Affairs extend coverage to adjacent R&D workflows.

The company's technical differentiator is the NavaX cognitive computing engine, launched in late 2023, which delivers GenAI and Agentic AI capabilities across the entire platform. NavaX powers the NavaX Agents suite (MedDRA Coding Agent, Signals Agents, Distribution Agents, Intelligence Agents), NavaX Translation (via partnership with TransPerfect Life Sciences), and the newly launched XDI (Data Intelligence Cortex), a federated data intelligence platform unifying clinical, regulatory, PV, and quality data. The platform processes over 700,000 safety cases annually as of 2025, scaling to a projected 2.5 million by mid-2026, providing a proprietary data flywheel. Notable integrations include PubMed/Medline/Embase (literature), Spotfire (analytics), and AWS/Azure/Google/Snowflake infrastructure.

ArisGlobal operates a subscription SaaS revenue model with enterprise, quote-based pricing negotiated annually per customer. Go-to-market is direct enterprise field sales complemented by a partner ecosystem of system integrators (Accenture, Cognizant, Pinaxis, SYNRG, Navitas) and technology partners (AWS, Microsoft, Google, Snowflake). The company serves 220+ enterprise customers across global pharmaceutical companies (including 3 of the world's top 10 and named customers Roche, AstraZeneca, Boehringer Ingelheim, Astellas), CROs (EPS Corporation, Nippon Shinyaku), and government health authorities (FDA, Health Canada, NMPA). Distribution is global with offices in the United States, United Kingdom, Ireland, Germany, Croatia, Japan, China, and India; annual Breakthrough events serve as flagship GTM touchpoints for major product launches.

ArisGlobal firmographics

Firmographics
Name
ArisGlobal
Legal name
ArisGlobal LLC
Website
https://arisglobal.com
Company type
Private
Founded year
1987
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
ArisGlobal is a private, PE-backed SaaS provider of AI-native life sciences R&D compliance software covering pharmacovigilance, regulatory affairs, quality, and medical affairs, serving 220+ global pharma, CRO, and health authority customers via its LifeSphere platform and NavaX cognitive engine.
Ownership category
akta.pro rank

ArisGlobal industry classification

Industry
Product category
Life Sciences R&D Software
NAICS
Software Publishers (5132)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLAGAJAK
Pharmacovigilance & Drug Safety Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAL
Regulatory Information Management (RIM) & Submission Publishing Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAC
Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

  • Pharmacovigilance software
  • Regulatory information management
  • Drug safety solutions
  • Life sciences compliance software
  • Medical affairs platform

Where ArisGlobal is headquartered

Location

Headquarters

HQ city
Waltham
HQ country
United States
HQ region
North America

Offices9 records

Markets served

ArisGlobal business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. SaaS Platform Subscriptions (LifeSphere): ArisGlobal operates on a subscription/SaaS model for its LifeSphere platform, charging enterprise customers recurring fees for access to pharmacovigilance, regulatory, quality, and medical affairs software. The platform is described as a next-generation SaaS safety and regulatory platform, with cloud-based deployment and multi-tenant architecture enabling scalable compliance. Pricing is quote-based and negotiated at the enterprise level.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise SaaS subscription — pricing not publicly disclosed

Go-to-market motion2 records

Distribution channels1 record

Marketing channels7 records

ArisGlobal product offering

Product offering

Core offering

ArisGlobal provides LifeSphere, an AI-first multi-tenant SaaS platform for life sciences R&D that unifies pharmacovigilance (drug safety), regulatory affairs, quality management, and medical affairs on a single cloud platform. The platform is powered by NavaX, a next-generation cognitive computing engine delivering GenAI and Agentic AI capabilities, and includes the MultiVigilance end-to-end automated touchless case processing system, AI-driven safety intake, signal detection, regulatory submissions, IDMP compliance (SPORIFY), and federated data intelligence via XDI.

Product overview

ArisGlobal offers LifeSphere, a unified platform-plus-modules architecture for life sciences R&D with integrated solutions across Safety, Regulatory, Quality, and Medical Affairs. The core LifeSphere Safety platform provides end-to-end pharmacovigilance via MultiVigilance (touchless case processing), Advanced Intake (GenAI-powered data extraction), Literature Intelligence, ReporterX, Advanced Signals, Business Intelligence, Document Distribution, and Advanced Compliance Docs. LifeSphere Regulatory spans RIM, Product Compliance, Documents, Submissions, Labeling, Analytics, Health Authority Interactions, and Regulatory Intelligence. LifeSphere Medical Affairs and LifeSphere Quality extend the platform. NavaX serves as the AI cognitive engine powering GenAI and Agentic AI capabilities across all modules, while XDI provides federated data intelligence. SPORIFY addresses IDMP compliance. All modules interoperate within the LifeSphere Unify R&D compliance platform.

Differentiator

Problem solved

Functional benefit

Brands

  • LifeSphere: AI-powered SaaS platform for life sciences R&D covering Safety, Regulatory, Quality, and Medical Affairs
  • NavaX
  • XDI (Data Intelligence Cortex)
  • SPORIFY
  • MultiVigilance
  • Advanced Intake
  • Literature Intelligence
  • ReporterX
  • Advanced Signals
  • Business Intelligence
  • Document Distribution
  • Advanced Compliance Docs

Products and services

  • LifeSphere Safety Unified, next-generation SaaS safety platform providing end-to-end pharmacovigilance operations with touchless case processing, scalable compliance, and standardized global workflows. Powered by NavaX AI capabilities. For global pharma, biotech, and CRO safety teams.
  • MultiVigilance End-to-end automated touchless case processing system for pharmacovigilance operations. Built to help safety teams achieve scalable, efficient, and harmonized case management while improving patient safety and compliance. Extended to medical device safety compliance.
  • Advanced Intake Safety case intake automation solution leveraging cutting-edge GenAI and LLMs to streamline collection of safety data from diverse sources. Achieves up to 65% increased intake efficiency with over 90% data extraction accuracy.
  • Literature Intelligence System-agnostic, GenAI-powered solution for literature intake and assessment. Automates workflows for literature screening from days to minutes, replacing manual processes with end-to-end automation for increased efficiency and data accuracy.
  • ReporterX Intelligent front-end patient data collection and reporting application powered by NavaX. Secure mobile and web applications enabling stakeholders to report adverse events, medical information, and product quality complaints with AI-assisted capabilities across 32+ languages.
  • Advanced Signals Next-generation signaling innovation setting a new standard in safety signaling via end-to-end signal and risk management. Includes AI-powered Signals Intelligence and Signals Agents for agentic AI-powered decision-making in signal management.
  • Business Intelligence Unified hub for safety reporting, analytics, and visualization. Provides over 50 out-of-the-box industry-standard reports for regulatory, compliance, and operational use, with intelligent analytics powered by Spotfire.
  • Document Distribution Single automated platform for oversight and distribution of safety content. Enables real-time distribution of safety reports to key stakeholder groups with audit readiness and customizable dashboards.
  • Advanced Compliance Docs Unified platform for managing safety documents and data powered by NavaX. Centralized solution for creating, storing, and managing medical writing, PSMF, PVAs and other critical safety documentation with up to 70% faster medical authoring.
  • LifeSphere Regulatory Comprehensive regulatory affairs platform transforming operations with GenAI and Agentic AI capabilities powered by NavaX. Seamlessly brings together data, content, and processes across end-to-end regulatory lifecycle.
  • LifeSphere Medical Affairs Medical affairs platform enabling seamless information flow and automation across Medical Affairs, Safety, and Product Complaints. Natively integrated with Safety and Quality systems via LifeSphere Unify.
  • LifeSphere Quality Complete solution for quality management and documentation needs of life sciences companies across R&D, Clinical, Regulatory, Pharmacovigilance, and Manufacturing with industry-specific requirements.
  • NavaX Next-gen cognitive computing engine accelerating application of artificial intelligence across LifeSphere platforms. Powers GenAI and Agentic AI capabilities including automation, translation, signal detection, and intelligent agents for life sciences R&D.
  • NavaX Agents Suite of AI-powered autonomous agents operating within LifeSphere Unify platform. Includes MedDRA Coding Agent (Frost & Sullivan 2025 New Product Innovation Award winner, up to 80% efficiency gains), Signals Agents, Distribution Agents, and Intelligence Agents for regulatory and safety operations.
  • NavaX Translation Translation solution developed through partnership with TransPerfect Life Sciences, embedding certified pharma-grade translation directly into LifeSphere Safety workflows. Reduces translation time from approximately 5 hours to under 1 minute per case, with over 95% data accuracy.
  • XDI (Data Intelligence Cortex) Federated data intelligence solution transforming regulated life sciences data into explainable, decision-grade intelligence across pharmacovigilance, regulatory, medical affairs, quality, and benefit-risk functions without requiring data consolidation.
  • SPORIFY AI-powered solution for SPOR and ISO IDMP compliance, helping track global regulatory changes and accelerate compliance with pharmaceutical data standards.

Quantifiable outcome

  • Up to 65% increased efficiency via safety case intake automation
  • +14 more outcomes

Companies that use ArisGlobal

Customer profile

Named customers6 records

Segments3 records

Ideal customer profiles3 records

ArisGlobal technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability12 records

Feature10 records

ArisGlobal partnerships and signals

Strategic signal

Partnerships

Twelve partnerships are on record, tiered core, major and minor.

  • TransPerfect Life SciencescoreStrategic or Co-development Partner · 26 February 2026Strategic partnership to embed certified, pharma-grade translation directly into LifeSphere Safety workflows via NavaX Translation. The solution integrates AI-powered language detection and expert human linguists to reduce case translation time from approximately 5 hours to under 1 minute. NavaX Translation leverages TransPerfect's certified translation capabilities to enable compliant multilingual pharmacovigilance operations. The platform currently processes over 1 million safety cases with projections to scale to 2.5 million cases by mid-2026.
  • CelegencecoreStrategic or Co-development Partner · 19 February 2025Strategic partnership to empower life sciences regulatory transformation. Celegence specializes in regulatory compliance and submission solutions, and the partnership aims to enhance ArisGlobal's regulatory offerings and enable faster compliance for shared customers.
  • SiterocoreStrategic or Co-development Partner · 6 September 2024Expanded strategic partnership to enable best-in-class capabilities across the complete drug development technology platform. The partnership integrates ArisGlobal's safety and regulatory solutions with Sitero's clinical trial technology suite for end-to-end drug development coverage.
  • AccenturecoreImplementation/ SI/ Consulting PartnerSystem integrator partner within the ArisGlobal Partner Network. Accenture provides consulting and implementation services to help deploy and customize ArisGlobal's LifeSphere platform for enterprise customers across the life sciences sector.
  • CognizantmajorImplementation/ SI/ Consulting PartnerSystem integrator and business process partner within the ArisGlobal Partner Network. Cognizant provides implementation and consulting services for ArisGlobal platform deployments.
  • PinaxisminorImplementation/ SI/ Consulting PartnerSystem integrator partner within the ArisGlobal Partner Network providing implementation services for ArisGlobal solutions.
  • SYNRGminorImplementation/ SI/ Consulting PartnerSystem integrator and business process partner within the ArisGlobal Partner Network.
  • Navitas (Sitero)minorImplementation/ SI/ Consulting PartnerSystem integrator partner within the ArisGlobal Partner Network (listed alongside Sitero branding).
  • AWS (Amazon Web Services)coreTechnology or IntegrationTechnology partner providing cloud infrastructure for ArisGlobal's SaaS platform. AWS enables the scalable, secure cloud deployment of LifeSphere across global customers.
  • MicrosoftcoreTechnology or IntegrationTechnology partner providing cloud infrastructure (Azure) and potentially AI/ML capabilities supporting ArisGlobal's platform.
  • GooglemajorTechnology or IntegrationTechnology partner within the ArisGlobal Partner Network, providing cloud infrastructure and potentially AI/ML capabilities.
  • SnowflakemajorTechnology or IntegrationTechnology partner providing data cloud infrastructure enabling ArisGlobal's cross-domain data integration and analytics capabilities.

Scale indicators9 records

Recent moves6 records

Expansion highlights7 records

ArisGlobal competitors and assessment

Company assessment

Direct peers

  • Veeva Systems: Veeva's Vault Safety, Vault RIM, Vault Quality, and Vault Submissions directly compete with ArisGlobal's LifeSphere platform across pharmacovigilance, regulatory information management, and quality. Veeva is the most entrenched life sciences SaaS platform with deeper CRM and commercial footprint. ArisGlobal's COO previously led Veeva's Vault Safety practice.
  • Instem: Instem provides software and services for safety assessment, regulatory submissions (Submit suite), and pre-clinical informatics. Directly comparable to ArisGlobal's safety/regulatory modules, particularly for CRO and mid-size pharma segments.
  • Honeywell (Sparta Systems TrackWise): Honeywell's TrackWise enterprise QMS platform competes directly with ArisGlobal's LifeSphere Quality and Quality Documents modules in regulated life sciences. Broader Honeywell portfolio includes process automation for manufacturing quality.
  • Ennov: Ennov provides a unified SaaS platform covering Pharmacovigilance, Regulatory (RIM), and Quality Management for life sciences, closely mirroring ArisGlobal's LifeSphere Safety/Regulatory/Quality portfolio. Mid-size player specializing in the same regulatory and compliance workflows for mid-market pharma.

Emerging players

  • Clario: Clario (formerly Bioclinica, where ArisGlobal CEO Aman Wasan previously led Safety and Regulatory Services) provides clinical and safety technology solutions for clinical trials. Partial overlap with ArisGlobal's safety intake and clinical trial informatics via Sitero partnership.
  • MaxisIT: MaxisIT provides AI-enabled clinical trial and safety technology (EDC, RTSM, safety) targeting mid-size pharma and CROs. Comparable scope to ArisGlobal's clinical informatics modules and pharmacovigilance offerings for similar customer profiles.

Broad incumbents

  • IQVIA: IQVIA combines technology (e.g., EDC, RTSM, safety) with CRO and real-world evidence services. Its technology arm competes for life sciences compliance workflows, while its broader services portfolio makes it a one-stop alternative to ArisGlobal's pure-software focus.
  • Parexel International: Parexel is a major CRO with proprietary technology platforms (e.g., PeriNurse, eProm) supporting pharmacovigilance and clinical operations. Competes with ArisGlobal's CRO-targeted MultiVigilance offering through bundled services rather than standalone SaaS.
  • Dassault Systèmes (Medidata): Medidata (a Dassault Systèmes brand) offers the Rave Clinical Cloud (EDC/CTMS/eCOA), BIOVIA for scientific informatics, and broader 3DEXPERIENCE platform for life sciences. Strong overlap with ArisGlobal's clinical trial informatics and scientific data management ambitions, especially relevant given the Sitero partnership.
  • Oracle Health Sciences: Oracle's Clinical One platform, Argus Safety (pharmacovigilance), and InForm compete across safety and clinical trials. As a large incumbent ERP/cloud vendor, Oracle offers life sciences capabilities as part of a broader technology portfolio rather than specializing in PV/RIM the way ArisGlobal does.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights8 records

Customer concentration

ArisGlobal social profiles

Digital presence

ArisGlobal compliance and trust

Trust signal

Compliance3 records

ArisGlobal financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ArisGlobal leadership team

Management profile

Number of profiles

Profiles9 records

ArisGlobal subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

ArisGlobal funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ArisGlobal M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ArisGlobal

What does ArisGlobal do?

ArisGlobal provides LifeSphere, an AI-first multi-tenant SaaS platform for life sciences R&D that unifies pharmacovigilance (drug safety), regulatory affairs, quality management, and medical affairs on a single cloud platform. The platform is powered by NavaX, a next-generation cognitive computing engine delivering GenAI and Agentic AI capabilities, and includes the MultiVigilance end-to-end automated touchless case processing system, AI-driven safety intake, signal detection, regulatory submissions, IDMP compliance (SPORIFY), and federated data intelligence via XDI.

Is ArisGlobal a public or private company?

ArisGlobal is a private company. It is classified as private equity controlled and is currently operating.

When was ArisGlobal founded?

ArisGlobal was founded in 1987. It employs 1,001 to 5,000 people.

Where is ArisGlobal based?

ArisGlobal is headquartered in Waltham, United States, in the North America region.

How does ArisGlobal make money?

One revenue line is on record: saaS Platform Subscriptions (LifeSphere).

Who are ArisGlobal's main competitors?

Direct peers on record are Veeva Systems, Instem, Honeywell (Sparta Systems TrackWise) and Ennov. Emerging players are Clario and MaxisIT. Broad incumbents are IQVIA, Parexel International, Dassault Systèmes (Medidata) and Oracle Health Sciences.

Does ArisGlobal have an API?

No public API is recorded for ArisGlobal.

What industry is ArisGlobal in?

ArisGlobal's product category is Life Sciences R&D Software. Its primary akta.pro industry code is HLAGAJAK, Pharmacovigilance & Drug Safety Software, with a secondary code of HLAGAJAL, Regulatory Information Management (RIM) & Submission Publishing Software. Its NAICS code is 5132 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EuropaWireDassault Systèmes Completes $1.8 Billion ArisGlobal Acquisition and Unifies Life Sciences AI OfferingDassault Systèmes completed its $1.8 billion cash acquisition of ArisGlobal, with up to $200 million in additional consideration tied to AI-related revenue milestones. The company will integrate ArisGlobal with BIOVIA and MEDIDATA into a unified AI-native platform, and appointed Dr. Ashwini Zenooz as CEO of the Life Sciences and Healthcare sector.TradingViewDSY: Higher FY26 objectives, expanding margins and a major Life Sciences AI acquisitionDassault Systèmes raised FY26 objectives after Q3 non-IFRS revenue grew 5% ex-FX and operating margin rose 1.5 percentage points. ARR reached €4.505bn, and the ArisGlobal acquisition advanced the unified Life Sciences AI platform.TradingViewDSY: Q3 growth, cash generation and raised FY26 objectives accompanied the ArisGlobal acquisitionDassault Systèmes reported Q3 non-IFRS revenue growth of 6% and EPS of 10% year-over-year, with ARR rising 6% excluding FX and cash conversion at 111% YTD. The company raised FY26 revenue and EPS objectives, and the ArisGlobal acquisition strengthens its unified Life Sciences AI platform.Stock TitanDassault Systèmes completes $1.8B ArisGlobal acquisitionDassault Systèmes completed its acquisition of ArisGlobal for $1.8 billion in cash, with up to $200 million in additional consideration tied to AI-related revenue milestones. The deal unites its life sciences and healthcare capabilities into a unified AI platform, and Dr. Ashwini Zenooz was appointed to lead the sector.Market ScoopClinical Data Analytics Solutions Market GrowthA market report projects the global clinical data analytics solutions market to reach US$ 11.8 billion by 2034, up from US$ 5.3 billion in 2024, at an 8.3% CAGR. North America held over 43.6% share, cloud deployment led at 55.6%, and clinical trials applications at 43.6%. Recent deals include Dassault Syst\u00e8mes' US$ 1.8 billion acquisition of ArisGlobal.PrtimesCosmetovigilance Market Size, Growth Forecast to 2034: Global Focus on Cosmetic Product Safety – PR TimesThe global cosmetovigilance market is projected to grow from US$ 12.01 billion in 2025 to US$ 18.72 billion by 2034, driven by increasing consumer awareness of product safety and stricter regulatory compliance requirements. Key industry players including Oracle Corporation, ArisGlobal, IQVIA, and Accenture are providing advanced data management and risk assessment solutions to support post-market surveillance. This expansion reflects the growing necessity for cosmetic manufacturers to implement robust adverse event reporting systems amid a rapidly expanding beauty and personal care sector.TechnologymagazineDassault Connects Isolated Healthcare Systems With $2bn DealDassault Systèmes has acquired ArisGlobal, an AI-native compliance platform, for $2 billion in a deal that links post-market safety data with research and clinical trial information for the first time. ArisGlobal processes more than 12 million patient safety reports annually and serves more than 200 customers, including half of the top 50 global biopharma companies. The acquisition completes a digital thread on Dassault's 3DEXPERIENCE platform by adding regulatory compliance and post-market safety operations to existing BIOVIA and Medidata tools, enabling earlier detection of emerging safety signals and shorter discovery-to-approval cycles.YahooDassault Buys ArisGlobal in Up to $2 Billion AI Software DealDassault Systemes, a French software company specializing in virtual twin technology, has agreed to acquire ArisGlobal, a U.S.-based enterprise compliance platform for the life sciences industry, for up to $2 billion — $1.8 billion in cash plus up to $200 million tied to AI-related revenue milestones. The acquisition from Swedish private equity firm Nordic Capital represents Dassault's first major deal since removing its chairman in February following a 26% share price decline this year driven by investor concerns over AI disruption in software. The deal is expected to address weakness in Dassault's life sciences division, which posted a 4% revenue decline to 252 million euros in Q2, by adding AI-powered capabilities in drug development, regulatory compliance, and safety monitoring serving over 200 life sciences customers.YahooDassault Buys ArisGlobal in Up to $2 Billion AI Software DealDassault Systemes, a French software company, has agreed to acquire ArisGlobal, a U.S.-based enterprise compliance platform serving the life sciences industry, for up to $2 billion (including $1.8 billion in cash and up to $200 million in AI-related revenue milestones). Nordic Capital, a Swedish private equity group, sold ArisGlobal, which serves more than 200 customers and uses AI to support drug development, regulatory compliance, and safety monitoring. The acquisition marks Dassault's first major move since removing its chairman in February following a 26% decline in its share price this year, as the company seeks to strengthen its life sciences division, which has reported declining revenues for two consecutive quarters.GurufocusDassault Buys ArisGlobal in Up to $2 Billion AI Software DealDassault Systèmes, a French software company specializing in virtual twins, has agreed to acquire ArisGlobal, a U.S.-based enterprise compliance platform serving the life sciences industry, for up to $2 billion ($1.8 billion in cash plus $200 million tied to AI-related revenue milestones). ArisGlobal, currently owned by Swedish private equity firm Nordic Capital, uses artificial intelligence to support drug development, regulatory compliance, and safety monitoring for more than 200 life sciences customers. The acquisition represents Dassault's first major move since removing its chairman in February following a steep decline in share price, as investors raised concerns that emerging AI tools could disrupt established software businesses, and aims to address weakness in Dassault's life sciences division.